Lung Cancer Treatment

Yes. The international patient centre issues visa invitation letters, arranges airport pickup and hospital transfers, provides English speaking coordinators, organises medical interpretation in Arabic, Russian and other languages on request, and helps book accommodation close to the hospital.

Yes. Imaging, pathology reports and treatment history can be submitted for remote review. The multidisciplinary team returns a written opinion covering diagnosis, the treatment options available at HYGEIA and the expected care plan, so a decision can be made before committing to travel.

Send the most recent imaging on disc or film together with the written report, the pathology report, recent blood tests, a summary of treatment received so far and a list of current medicines with doses. Records in English are easiest, but scans and reports in any language can be reviewed and translated by our team.

Yes. An English speaking coordinator is assigned to every international patient, and interpretation in Arabic, Russian and other languages can be arranged for consultations, ward rounds and consent discussions. Key documents such as the treatment plan and discharge instructions are provided in English.

Yes. A companion can stay with you in the room, and single rooms are available on request. Companions are welcome to attend consultations and be present when the treatment plan is explained.

No. Early stage tumours are usually removed surgically, but small or centrally located lesions may be better treated with stereotactic radiotherapy, and advanced disease is managed mainly with targeted therapy, immunotherapy or chemotherapy. The recommendation follows stage, molecular profile and lung function.

Treatment then focuses on systemic control. Testing looks for driver mutations such as EGFR, ALK and ROS1, because targeted drugs can control tumours for long periods with fewer side effects than chemotherapy. Immunotherapy is considered according to PD-L1 expression.